GRAIL Multi-Cancer Early Detection Test

Space For Wellness is thrilled to introduce the Galleri™ Multi-Cancer Early Detection (MCED) Test. With one in two men and one in three women facing a cancer diagnosis in their lifetime, and one in five succumbing to the disease, early detection is crucial. Currently, over 70% of cancer deaths stem from cancers that are not part of routine screenings. Traditional screenings cover about a quarter of cancers, including breast (mammogram/ultrasound), colorectal (colonoscopy), prostate (PSA testing), lung in high-risk individuals (low-dose CT scan), and cervical (PAP smear). Most cancers remain undetected until advanced stages, where treatment options are often limited, leading to poorer outcomes.

The MCED Test changes this by detecting over 50 types of cancer through a simple blood draw, including many that are not typically screened for today. Early detection can significantly improve treatment success and survival rates. If a cancer signal is identified, the test can accurately indicate where in the body the cancer is likely located, aiding you and your healthcare provider in planning the next steps.

It’s important to note that the MCED Test is designed to complement, not replace, the existing cancer screening tests recommended by your healthcare provider.